MARYLAND ONCOLOGY HEMATOLOGY

Oct. 24, 2024

3:22 p.m.

SPECIAL ADVERTISING SECTION

Expert Care. Close to Home.

Patient-Centered Approach

Maryland Oncology Hematology provides patients with advanced, comprehensive cancer therapies in a community setting that allows patients to receive care near their support systems. Our highly trained and experienced physicians work closely with a talented clinical team that is sensitive to the needs of cancer patients and their caregivers. The best of care, close to home.

Patients can be assured that as an independent practice, MOH physicians are able to send patients to the best specialists or make recommendations based on specific care needs. We are never beholden to a health system or network. Unlike some of the major hospitals, our doctors are focused solely on oncology, giving patients the expert care that they deserve.

Maryland Oncology Hematology is a community-based practice, entirely owned and run by Maryland physicians. Our team is devoted to providing state-of-the-art patient care for hematology and oncology, working on behalf of our community for the benefit of patients.

Expertise in One Place

Our board-certified oncology and hematology experts are dedicated solely to treating cancer and blood disorders. Our nationally recognized providers work together as a group to provide the best possible treatment.

Chemotherapy and other medical oncology therapies destroy cancer cells, oftentimes with targeted approaches that cause less damage to normal, healthy cells.

Immunotherapy treatment uses drugs that target a body’s own immune system to help fight cancer.

Hematology treatment for blood disorders using the latest in therapies and technologies. Our physicians work closely with radiation oncologists, pharmacists, and other specialists to ensure comprehensive care for our patients.

Clinical trials are cutting edge, innovative research studies that patients can participate in. These studies test the safety and effectiveness of new treatments to find better ways to diagnose and treat cancer and are often working on new therapies. In partnership with the Sarah Cannon Research Institute, MOH offers unprecedented access into numerous clinical trials.